KIMBERLY CLARK CORP
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $KMB in the last 30 days.
See all $KMB insider activity →Kimberly-Clark (KMB) extended the expiration date for its exchange offers of Kenvue (KVUE) notes to November 2, 2026. The offers are part of Kimberly-Clark's pending acquisition of Kenvue, with up to $7B in new notes to be issued. The exchange is contingent on the acquisition's completion and other conditions.
Wall Street faced volatility last week due to AI funding concerns, despite strong earnings. Meta's negative free cash flow and financing needs for AI investments led to a sell-off, impacting AI-related stocks. The Dow rose 0.4%, while the S&P 500 and Nasdaq fell 0.5% and 0.7% respectively. Investors rotated into defensive stocks like Kimberly-Clark and Johnson & Johnson. Apple gained 1.2% on strong iPhone Duo demand, while Qnity Electronics dropped 4.5% amid data center trade troubles.
Wall Street analyst research calls for Friday include upgrades for Hess Midstream LP (HESM) to Outperform, MSC Industrial (MSM) to Overweight, and SpaceX (SPCX) to Buy. Downgrades include Deckers Outdoor (DECK) to Underweight, Globe Life (GL) to Neutral, and NVR (NVR) to Underperform. Initiations include Guardant Health (GH) and Natera (NTRA) with Buy ratings. Markets saw declines, with Nasdaq down 2.6% and Treasury yields dropping sharply.
Over the past 7 days, AlphAI's AI scored 8 news stories mentioning KMB (KIMBERLY CLARK CORP). Coverage has been balanced: 1 bullish, 6 neutral, and 1 bearish.
Recent KMB coverage spans financial news, corporate actions and mergers & acquisitions.
Extension may delay settlement and keep pressure on KMB stock until November 2.
Defensive tilt may support KMB briefly.
Neutral new coverage.
New coverage may influence investor sentiment and modestly affect price.
Net takeaway is valuation and dividend sustainability concerns tied to cash coverage, partially offset by recent earnings beats and regulatory approvals easing deal risk.
AlphAI scores every news story that mentions KMB with an AI model for sentiment and relevance, and aggregates insider trades from KIMBERLY CLARK CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.
Kimberly-Clark (KMB) extended the expiration date for its exchange offers of Kenvue (KVUE) notes to November 2, 2026. The offers are part of Kimberly-Clark's pending acquisition of Kenvue, with up to $7B in new notes to be issued. The exchange is contingent on the acquisition's completion and other conditions.
2 min readWall Street faced volatility last week due to AI funding concerns, despite strong earnings. Meta's negative free cash flow and financing needs for AI investments led to a sell-off, impacting AI-related stocks. The Dow rose 0.4%, while the S&P 500 and Nasdaq fell 0.5% and 0.7% respectively. Investors rotated into defensive stocks like Kimberly-Clark and Johnson & Johnson. Apple gained 1.2% on strong iPhone Duo demand, while Qnity Electronics dropped 4.5% amid data center trade troubles.
3 min readWall Street analyst research calls for Friday include upgrades for Hess Midstream LP (HESM) to Outperform, MSC Industrial (MSM) to Overweight, and SpaceX (SPCX) to Buy. Downgrades include Deckers Outdoor (DECK) to Underweight, Globe Life (GL) to Neutral, and NVR (NVR) to Underperform. Initiations include Guardant Health (GH) and Natera (NTRA) with Buy ratings. Markets saw declines, with Nasdaq down 2.6% and Treasury yields dropping sharply.
3 min readCanaccord initiated coverage of Kimberly-Clark (KMB) with a Hold rating and a $105 price target, according to TheFly. The company recently priced $4.9 billion notes for its Kenvue deal. Other analysts have also adjusted their price targets and ratings for KMB.
1 min readJim Cramer called Kimberly-Clark a 'dividend king' with a high yield, despite recent underperformance. The company has a 54-year dividend growth streak but faces challenges like revenue misses and operational issues. Its acquisition of Kenvue adds uncertainty. Recent positive developments include better-than-expected Q3 guidance and regulatory approvals. The stock is up 10.11% year-to-date, with a yield of about 4.8%.
6 min readKimberly-Clark (KMB) received Chinese antitrust approval for its $40B acquisition of Kenvue (KVUE) on Oct. 10, following Brazil's approval. The deal is a major corporate transaction for both companies.
2 min readKIMBERLY CLARK CORP (KMB) filed an SEC Form 8-K — Other Events. Exhibit 99.1 Kimberly-Clark Corporation Announces Pricing of $4.9 Billion Private Offering of Senior Notes DALLAS, October 19, 2026 – Kimberly-Clark Corporation (NASDAQ: KMB) (“Kimberly-Clark”) announced today that it has priced a private offering (the “Offering”) of senior unsec
2 min readKimberly-Clark (KMB) plans to issue $4.9B in senior notes to fund its acquisition of Kenvue, expected to close by Q4 2026. If the deal misses its 2027 deadline, KMB must redeem the notes at 101% of their value. The company also launched an exchange offer for Kenvue's existing notes.
2 min readClorox (CLX) and Kimberly-Clark (KMB) are compared for their dividend payouts. CLX offers a 6.2% yield, but its dividends exceeded free cash flow in fiscal 2026. KMB yields 5.4%, with dividends covered by free cash flow. CLX's net debt increased post-acquisition, while KMB faces China-related sales challenges. Both companies' dividend policies and financial health are analyzed.
3 min readKimberly-Clark's stock rose 8% as it reported higher adjusted earnings and advanced in its $48.7B Kenvue acquisition. Q3 net sales were $4.134B, down from $4.150B a year ago. Adjusted EPS from continuing ops increased to $1.70 from $1.45. The company maintained its 2026 outlook, factoring in China's social-media disruptions. Final Q3 results are due Nov. 5.
2 min read
